0 CHECKOUT

PRODUCT FILTERS

REGION

31
27
23
23
19

COUNTRY

10
8
7
4
3

PRICE

28
40
87
140

PUBLISHED

3
5
12
140

PRODUCT TYPE

134
2
1
1
1
1

Generics

The global generics market is fast growing, driven by demand for cost-effective medicines and new availability of high value products. By now there are 17 generic companies with revenues in excess of US$1 billion, while there were only 12 in 2008/09.

The reports, books, and subscriptions listed under Research and Markets’ Generics category cover every aspect of this industry, such as market trends, forecasts, drivers and restraints, etc. They will allow you to identify business opportunities and assess the strategies of the major players. You can also investigate the latest international and national patent opportunities across a vast number of INNs (international non-proprietary names), taking into account key concerns such as expiry dates, national regulations, etc.

Key players featured in our publications includes Teva Pharmaceutical, Mylan, Sandoz, Watson Pharmaceuticals, Greenstone, Par Pharma, Hospira, Apotex, Mallinckrodt, Dr. Reddy's, and more. Show Less
Read more

Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars

The generic injectables sector exceeds US$11 2 billion and numerous high-value injectable products will face patent expiry in major markets over the next decade This critical new report evaluates the...

Published:  July 2011
Price:  From

Global Generics

Global Generics market was valued at US$123 billion in 2010, and has been estimated to reach US$ 180 billion by 2014, at a CAGR of 10 6% during 2011-14 Generics market remains a major growth area in...

Published:  August 2011
Price:  From

The Impact of Generics on Pharmaceutical Growth Opportunities - A Growing Threat that Offers Future Opportunities

While generic penetration has been on the rise in the major developed markets for some time, the current and continuing difficult economic environment is stimulating political and payer actions to accelerate...

Published:  October 2011
Price:  From

Generic Drugs in Consumer Health Global Overview 2011

Generic drugs are usually associated with prescription (Rx) drugs; however, they are infiltrating the consumer health landscape via “branded generics” and private label across the world. Significant...

Published:  July 2011
Price:  From

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

“Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases” provides detailed insight into the Asia-Pacific...

Published:  July 2011
Price:  From

Generics Threats and Opportunities: Mounting an Effective Defense Strategy

After years of relatively easy blockbuster profits, worldwide respect and investment, and loyal customer bases, the Pharmaceutical realm has undergone a seismic shift Today, the branded Pharmaceutical...

Published:  June 2011
Price: 

Generic and Innovative Drugs Market in Russia and Ukraine 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013

Generic and innovative drugs market in Russia and Ukraine 2011 is the first separate edition of a report providing a comprehensive study of recent trends, developments and forecasts in the generic and...

Published:  March 2011
Price:  From

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues Summary GBI Research has released its research “Generic Growth Strategies - Manufacturers...

Published:  May 2011
Price:  From

Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market

“Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market”, which provides insights into sleep disorders therapeutics sales and price forecasts...

Published:  April 2011
Price:  From

Generic Drug Market in Japan 2010

Generic Drug Market in Japan 2010 is a comprehensive resource book on the current generic drug market in Japan It provides you with a full picture of the market by covering market size, market share,...

Published:  December 2010
Price: 

Generic Drug Market in Japan 2010

Generic Drug Market in Japan 2010 is a comprehensive resource book on the current generic drug market in Japan It provides you with a full picture of the market by covering market size, market share,...

Published:  December 2010
Price: 

Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets

Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets Summary GBI Research’s new report, “Patent Strategies - Effective Strategies...

Published:  December 2010
Price:  From

Generic Substitution: Taking a Narrow View?

As health care expenditures rise, governments, payers, healthcare providers and patients alike are focused intently on one thing: capping runaway costs For the generics industry, it heralds a boom-time...

Published:  November 2010
Price:  From

Branded vs Generic Drugs in Latin America

On every border, across every frontier of Latin America, a revolution is underway Prefaced by the ground-breaking Hatch-Waxman Act of 1984, the war for market share between generic and branded pharmaceuticals...

Published:  October 2010
Price:  From

Partnering in the Global Generics Industry 2010 - A Guide to Companies

"Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countries The operating environment for generics companies is changing rapidly as the industry matures and growth focuses...

Published:  October 2010
Price:  From

Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth

“Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth” The report provides a detailed insight into the global Active Pharmaceutical Ingredients...

Published:  October 2010
Price:  From

Pharma Market Insights: Generics

Biosimilars Biobetters Branded and generic drugs Specialty generics Pay-for-delay Individually, they represent big questions for the pharmaceutical industry Together—in Pharma Market Insights: Generics...

Published:  September 2010
Price:  From

Branded Generics: A Gateway to Emerging Markets

Around the globe, emerging markets are on the move From Brazil, Russia and India to China, Turkey, Mexico and South Korea, experts predict emerging markets will represent 70 percent of industry growth...

Published:  June 2010
Price:  From

Branded vs Generic Drugs in Russia and CEE – Expert Insights

Across Russia and former Communist countries in Central and Eastern Europe, the battle for market share is being played out on three fronts between patented drugs, branded and commodity generics And...

Published:  July 2010
Price:  From

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

“The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 – Strategies to Counter Generic Erosion in Key Markets", provides in-depth analysis of the unmet needs, drivers and barriers...

Published:  May 2010
Price:  From
Loading Indicator

Our Clients